SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling
eLife · 2025
DOI: 10.7554/elife.100248 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Fansen Meng und 11 weiteren Autor:innen. Beteiligte Einrichtung: McGill Gene Editing Lab, The Texas Heart Institute, Houston, United States. Hauptthemen laut MEDLINE: Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
The Hippo pathway controls organ development, homeostasis, and regeneration primarily by modulating YAP/TEAD-mediated gene expression. Although emerging studies report Hippo-YAP dysfunction after viral infection, it is largely unknown in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we analyzed RNA sequencing data from human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and SARS-CoV-2-infected human lung samples, and observed a decrease in YAP target gene expression. In screening SARS-CoV-2 nonstructural proteins, we found that nonstructural protein 13 (NSP13), a conserved coronavirus helicase, inhibits YAP transcriptional activity independent of the upstream Hippo kinases LATS1/2. Consistently, introducing NSP13 into mouse cardiomyocytes suppresses an active form of YAP (YAP5SA) in vivo . Subsequent investigations on NSP13 mutants revealed that NSP13 helicase activity, including DNA binding and unwinding, is crucial for suppressing YAP transactivation in HEK293T cells. Mechanistically, TEAD4 serves as a platform to recruit NSP13 and YAP. NSP13 likely inactivates the YAP/TEAD4 transcription complex by remodeling chromatin to recruit proteins, such as transcription termination factor 2 (TTF2), to bind the YAP/TEAD/NSP13 complex. These findings reveal a novel YAP/TEAD regulatory mechanism and uncover molecular insights into Hippo-YAP regulation after SARS-CoV-2 infection in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- McGill Gene Editing Lab, The Texas Heart Institute, Houston, United States.
- Cardiomyocyte Renewal Laboratory, The Texas Heart Institute, Houston, United States.
- Department of Integrative Physiology, Baylor College of Medicine, Houston, United States.
- The Heart Institute, Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, United States.
ORCID-Profile: Fansen Meng, Xiao Li, James F Martin
Förderung
- NHLBI NIH HHS
- American Heart Association
- National Heart, Lung, and Blood Institute
Zitieren
APA
Meng, F., Kim, J. H., Tsai, C. R., Steimle, J. D., Wang, J., Shi, Y., Li, R. G., Xie, B., Deshmukh, V., Liu, S., Li, X., & Martin, J. F. (2025). SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling. eLife. https://doi.org/10.7554/elife.100248
Vancouver
Meng F, Kim JH, Tsai CR, Steimle JD, Wang J, Shi Y, et al. SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling. eLife. 2025. doi:10.7554/elife.100248
BibTeX
@article{Meng2025,
author = {Meng, Fansen and Kim, Jong Hwan and Tsai, Chang-Ru and Steimle, Jeffrey D and Wang, Jun and Shi, Yufeng and Li, Rich G and Xie, Bing and Deshmukh, Vaibhav and Liu, Shijie and Li, Xiao and Martin, James F},
title = {SARS-CoV-2 NSP13 interacts with TEAD to suppress Hippo-YAP signaling},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.100248}
}
EUVIMED